NVN1 (Stavzor 250 mg)

Generic Name: valproic acid

Pill imprint NVN1 has been identified as Stavzor 250 mg.

Stavzor is used in the treatment of schizoaffective disorder; migraine prevention; seizure prevention; seizures; mania (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Stavzor 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for NVN1 (Stavzor 250 mg)

Stavzor 250 mg NVN1
Stavzor
Generic Name:
valproic acid
Imprint:
NVN1
Strength:
250 mg
Color:
Orange
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
N - Not a controlled drug
Manufacturer:
JDS Pharmaceuticals LLC
National Drug Code (NDC):
68968-3250
Inactive Ingredients:
ammonia
gelatin
glycerin
methacrylic acid - methyl methacrylate copolymer (1:1)
triethyl citrate
water
FD&C Yellow No. 6

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)